As of November 2024, Lavipharm has a market cap of $149.27M. This makes Lavipharm the world's 19075th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $164.57M | 10.80% |
2023 | $148.52M | 107.29% |
2022 | $71.65M | -33.79% |
2021 | $108.22M | 247.31% |
2018 | $31.16M | 1.83% |
2017 | $30.60M | 90.70% |
2016 | $16.05M | -38.57% |
2015 | $26.12M | 2.19% |
2014 | $25.56M | 5.38% |
2013 | $24.26M | -18.75% |
2012 | $29.85M | - |